The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review
Authors
Keywords
-
Journal
TERAPEVTICHESKII ARKHIV
Volume 95, Issue 9, Pages 796-801
Publisher
Consilium Medicum
Online
2023-11-04
DOI
10.26442/00403660.2023.09.202367
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases
- (2022) Jonatan Barrera-Chimal et al. Annual Review of Physiology
- The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers
- (2022) Yuta Tezuka et al. CURRENT HYPERTENSION REPORTS
- Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease
- (2022) Edgar Lerma et al. POSTGRADUATE MEDICINE
- Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes
- (2022) Peter Rossing Kidney International Supplements
- Aldosterone and mineralocorticoid receptor signaling as determinants of cardiovascular and renal injury: an extraordinary paradigm shift
- (2022) Murray Epstein Kidney International Supplements
- The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis
- (2022) James M. Luther et al. Kidney International Supplements
- The renin–angiotensin system biomolecular cascade: a 2022 update of newer insights and concepts
- (2022) Carlos M. Ferrario et al. Kidney International Supplements
- Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease
- (2022) Toshifumi Nakamura et al. Kidney International Supplements
- Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone—Translational Aspects and Clinical Perspectives across Multiple Organ Systems
- (2022) Peter Kolkhof et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chronic kidney disease in patients with type 2 diabetes: new targets of medicine action
- (2022) N. P. Trubitsyna et al. Diabetes Mellitus
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
- (2021) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel non‐steroidal mineralocorticoid receptor antagonists in cardiorenal disease
- (2021) Ulrich Kintscher et al. BRITISH JOURNAL OF PHARMACOLOGY
- Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology, mechanisms, and evidence from recent trials
- (2021) Ajay Chaudhuri et al. DIABETES OBESITY & METABOLISM
- Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy
- (2021) Peter Rossing et al. Kidney International Reports
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events in patients with diabetes and overt nephropathy: a meta-analysis of randomised controlled trials
- (2018) Fan Shunan et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Mineralocorticoid regulation of cell function: the role of rapid signalling and gene transcription pathways
- (2016) Gregory S Y Ong et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
- (2013) Nancy J. Brown Nature Reviews Nephrology
- Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions
- (2012) Leszek Tylicki et al. JOURNAL OF NEPHROLOGY
- Minireview: Aldosterone and Mineralocorticoid Receptors: Past, Present, and Future
- (2010) John W. Funder ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now